VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q56955657 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241120235737.0
008 241120nneanz||abbn n and d
035 ‎‡a (WKP)Q56955657‏
024 ‎‡a 0000-0002-4674-7244‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q56955657‏
100 0 ‎‡a Andrea Schneider‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Andrea Schneider‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A family with two female siblings with compound heterozygous FMR1 premutation alleles.‏
670 ‎‡a Author's A feasibility trial of Cogmed working memory training in fragile X syndrome‏
670 ‎‡a Author's A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male‏
670 ‎‡a Author's A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.‏
670 ‎‡a Author's A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder‏
670 ‎‡a Author's A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome.‏
670 ‎‡a Author's A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome‏
670 ‎‡a Author's A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome‏
670 ‎‡a Author's A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome‏
670 ‎‡a Author's Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome‏
670 ‎‡a Author's Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome.‏
670 ‎‡a Author's Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases‏
670 ‎‡a Author's Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers‏
670 ‎‡a Author's Aging in Fragile X Premutation Carriers‏
670 ‎‡a Author's Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study‏
670 ‎‡a Author's [Analysis of EEG coherence in examination of an automation deficit in reading-spelling disorder--a pilot study]‏
670 ‎‡a Author's Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers‏
670 ‎‡a Author's Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions‏
670 ‎‡a Author's Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome‏
670 ‎‡a Author's Brief report: Sensorimotor gating in idiopathic autism and autism associated with fragile X syndrome‏
670 ‎‡a Author's Case report: Dystonia in a fragile X carrier‏
670 ‎‡a Author's Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked FMR1 Gene‏
670 ‎‡a Author's Clinical and molecular correlates in fragile X premutation females.‏
670 ‎‡a Author's Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases‏
670 ‎‡a Author's Computerized Cognitive Training in Children With Autism and Intellectual Disabilities: Feasibility and Satisfaction Study‏
670 ‎‡a Author's Computerized Cognitive Training in Children With Autism and Intellectual Disabilities: Feasibility and Satisfaction Study (Preprint)‏
670 ‎‡a Author's Conversion disorder in women with the FMR1 premutation‏
670 ‎‡a Author's Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation.‏
670 ‎‡a Author's Developmental aspects of FXAND in a man with the FMR1 premutation‏
670 ‎‡a Author's Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome.‏
670 ‎‡a Author's Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations‏
670 ‎‡a Author's ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome‏
670 ‎‡a Author's ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI.‏
670 ‎‡a Author's Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS).‏
670 ‎‡a Author's Fentanyl overdose in a female with the FMR1 premutation and FXTAS‏
670 ‎‡a Author's Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s‏
670 ‎‡a Author's Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.‏
670 ‎‡a Author's Fragile X syndrome: an aging perspective.‏
670 ‎‡a Author's High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome‏
670 ‎‡a Author's Impact of Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins‏
670 ‎‡a Author's Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine‏
670 ‎‡a Author's Improving IQ measurement in intellectual disabilities using true deviation from population norms‏
670 ‎‡a Author's Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.‏
670 ‎‡a Author's Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles‏
670 ‎‡a Author's Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers‏
670 ‎‡a Author's Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encoding‏
670 ‎‡a Author's Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study‏
670 ‎‡a Author's Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.‏
670 ‎‡a Author's Metformin treatment in young children with fragile X syndrome‏
670 ‎‡a Author's Methadone use in a male with the FMRI premutation and FXTAS.‏
670 ‎‡a Author's Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study‏
670 ‎‡a Author's Parent-delivered touchscreen intervention for children with fragile X syndrome‏
670 ‎‡a Author's Phenotypes of hypofrontality in older female fragile X premutation carriers‏
670 ‎‡a Author's Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome‏
670 ‎‡a Author's Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome.‏
670 ‎‡a Author's Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders.‏
670 ‎‡a Author's Psychosis and catatonia in fragile X: Case report and literature review‏
670 ‎‡a Author's Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease‏
670 ‎‡a Author's The cognitive neuropsychological phenotype of carriers of the FMR1 premutation.‏
670 ‎‡a Author's Warburg effect linked to cognitive-executive deficits in FMR1 premutation‏
670 ‎‡a Author's Women with Fragile X-associated Tremor/Ataxia Syndrome‏
909 ‎‡a (orcid) 0000000246747244‏ ‎‡9 1‏
919 ‎‡a memantineeffectsonverbalmemoryinfragile10associatedtremorataxiasyndromefxtasadoubleblindbrainpotentialstudy‏ ‎‡A Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study‏ ‎‡9 1‏
919 ‎‡a lifetimeprevalenceofmoodandanxietydisordersinfragile10premutationcarriers‏ ‎‡A Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers‏ ‎‡9 1‏
919 ‎‡a influenceofthefragile10mentalretardationfmr1geneonthebrainandworkingmemoryinmenwithnormalfmr1alleles‏ ‎‡A Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles‏ ‎‡9 1‏
919 ‎‡a increasedprevalenceofseizuresinboyswhowereprobandswiththefmr1premutationandcomorbidautismspectrumdisorder‏ ‎‡A Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.‏ ‎‡9 1‏
919 ‎‡a improvingiqmeasurementinintellectualdisabilitiesusingtruedeviationfrompopulationnorms‏ ‎‡A Improving IQ measurement in intellectual disabilities using true deviation from population norms‏ ‎‡9 1‏
919 ‎‡a improvingfragile10associatedtremorataxiasyndromesymptomswithmemantineandvenlafaxine‏ ‎‡A Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine‏ ‎‡9 1‏
919 ‎‡a impactofpremutationonneurobehaviorandbioenergeticsinyoungmonozygotictwins‏ ‎‡A Impact of Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins‏ ‎‡9 1‏
919 ‎‡a highfunctioningmalewithfragile10syndromeandfragile10associatedtremorataxiasyndrome‏ ‎‡A High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome‏ ‎‡9 1‏
919 ‎‡a fragile10syndromeanagingperspective‏ ‎‡A Fragile X syndrome: an aging perspective.‏ ‎‡9 1‏
919 ‎‡a fragile10associatedtremorataxiasyndromeinfluenceofthefmr1geneonmotorfibertractsinmaleswithnormalandpremutationalleles‏ ‎‡A Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.‏ ‎‡9 1‏
919 ‎‡a fragile10associatedtremorataxiasyndromeinamaninhis30s‏ ‎‡A Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s‏ ‎‡9 1‏
919 ‎‡a fentanyloverdoseinafemalewiththefmr1premutationandfxtas‏ ‎‡A Fentanyl overdose in a female with the FMR1 premutation and FXTAS‏ ‎‡9 1‏
919 ‎‡a feasibilityreliabilityandclinicalvalidityofthetestofattentionalperformanceforchildrenkitapinfragile10syndromefxs‏ ‎‡A Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS).‏ ‎‡9 1‏
919 ‎‡a erpabnormalitieselicitedbywordrepetitioninfragile10associatedtremorataxiasyndromefxtasandamnestic1101‏ ‎‡A ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI.‏ ‎‡9 1‏
919 ‎‡a erpabnormalitieselicitedbywordrepetitioninfragile10associatedtremorataxiasyndrome‏ ‎‡A ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome‏ ‎‡9 1‏
919 ‎‡a elevatedfmr1mrnaandloweredfmrpadoublehitmechanismforpsychiatricfeaturesinmenwithfmr1premutations‏ ‎‡A Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations‏ ‎‡9 1‏
919 ‎‡a earlyinterventioncombinedwithtargetedtreatmentpromotescognitiveandbehavioralimprovementsinyoungchildrenwithfragile10syndrome‏ ‎‡A Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome.‏ ‎‡9 1‏
919 ‎‡a developmentalaspectsoffxandinamanwiththefmr1premutation‏ ‎‡A Developmental aspects of FXAND in a man with the FMR1 premutation‏ ‎‡9 1‏
919 ‎‡a decreasedfragile10mentalretardationproteinexpressionunderliesamygdaladysfunctionincarriersofthefragile10premutation‏ ‎‡A Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation.‏ ‎‡9 1‏
919 ‎‡a conversiondisorderinwomenwiththefmr1premutation‏ ‎‡A Conversion disorder in women with the FMR1 premutation‏ ‎‡9 1‏
919 ‎‡a computerizedcognitivetraininginchildrenwithautismandintellectualdisabilitiesfeasibilityandsatisfactionstudypreprint‏ ‎‡A Computerized Cognitive Training in Children With Autism and Intellectual Disabilities: Feasibility and Satisfaction Study (Preprint)‏ ‎‡9 1‏
919 ‎‡a computerizedcognitivetraininginchildrenwithautismandintellectualdisabilitiesfeasibilityandsatisfactionstudy‏ ‎‡A Computerized Cognitive Training in Children With Autism and Intellectual Disabilities: Feasibility and Satisfaction Study‏ ‎‡9 1‏
919 ‎‡a cognitiveandbehavioralimprovementinadultswithfragile10syndrometreatedwithmetformin2cases‏ ‎‡A Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases‏ ‎‡9 1‏
919 ‎‡a clinicalandmolecularcorrelatesinfragile10premutationfemales‏ ‎‡A Clinical and molecular correlates in fragile X premutation females.‏ ‎‡9 1‏
919 ‎‡a characterizationofthemetabolicclinicalandneuropsychologicalphenotypeoffemalecarriersofthepremutationinthe10linkedfmr1gene‏ ‎‡A Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked FMR1 Gene‏ ‎‡9 1‏
919 ‎‡a casereportdystoniainafragile10carrier‏ ‎‡A Case report: Dystonia in a fragile X carrier‏ ‎‡9 1‏
919 ‎‡a familywith2femalesiblingswithcompoundheterozygousfmr1premutationalleles‏ ‎‡A A family with two female siblings with compound heterozygous FMR1 premutation alleles.‏ ‎‡9 1‏
919 ‎‡a feasibilitytrialofcogmedworkingmemorytraininginfragile10syndrome‏ ‎‡A A feasibility trial of Cogmed working memory training in fragile X syndrome‏ ‎‡9 1‏
919 ‎‡a fragile10sibshipfromaconsanguineousfamilywithacompoundheterozygousfemaleandpartiallymethylatedfullmutationmale‏ ‎‡A A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male‏ ‎‡9 1‏
919 ‎‡a pilotopenlabelsingledosetrialoffenobaminadultswithfragile10syndrome‏ ‎‡A A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.‏ ‎‡9 1‏
919 ‎‡a randomizedcontrolledtrialofsertralineinyoungchildrenwithautismspectrumdisorder‏ ‎‡A A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder‏ ‎‡9 1‏
919 ‎‡a malecarriersofthefmr1premutationshowalteredhippocampalprefrontalfunctionduringmemoryencoding‏ ‎‡A Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encoding‏ ‎‡9 1‏
919 ‎‡a randomizeddoubleblindplacebocontrolledtrialofganaxoloneinchildrenandadolescentswithfragile10syndrome‏ ‎‡A A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome.‏ ‎‡9 1‏
919 ‎‡a randomizeddoubleblindplacebocontrolledtrialoflowdosesertralineinyoungchildrenwithfragile10syndrome‏ ‎‡A A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome‏ ‎‡9 1‏
919 ‎‡a randomizeddoubleblindplacebocontrolledtrialofminocyclineinchildrenandadolescentswithfragile10syndrome‏ ‎‡A A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome‏ ‎‡9 1‏
919 ‎‡a solutiontolimitationsofcognitivetestinginchildrenwithintellectualdisabilitiesthecaseoffragile10syndrome‏ ‎‡A A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome‏ ‎‡9 1‏
919 ‎‡a abnormaln400wordrepetitioneffectsinfragile10associatedtremorataxiasyndrome‏ ‎‡A Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome‏ ‎‡9 1‏
919 ‎‡a abnormalsemanticprocessinginfemaleswithfragile10associatedtremorataxiasyndrome‏ ‎‡A Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome.‏ ‎‡9 1‏
919 ‎‡a addictivesubstancesmayinducearapidneurologicaldeteriorationinfragile10associatedtremorataxiasyndromeareportof2cases‏ ‎‡A Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases‏ ‎‡9 1‏
919 ‎‡a agesofonsetofmoodandanxietydisordersinfragile10premutationcarriers‏ ‎‡A Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers‏ ‎‡9 1‏
919 ‎‡a aginginfragile10premutationcarriers‏ ‎‡A Aging in Fragile X Premutation Carriers‏ ‎‡9 1‏
919 ‎‡a allopregnanolonetreatmentimprovesplasmametabolomicprofileassociatedwithgabametabolisminfragile10associatedtremorataxiasyndromeapilotstudy‏ ‎‡A Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study‏ ‎‡9 1‏
919 ‎‡a analysisofeegcoherenceinexaminationofanautomationdeficitinreadingspellingdisorderapilotstudy‏ ‎‡A [Analysis of EEG coherence in examination of an automation deficit in reading-spelling disorder--a pilot study]‏ ‎‡9 1‏
919 ‎‡a assessmentofmolecularmeasuresinnonfxtasmalepremutationcarriers‏ ‎‡A Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers‏ ‎‡9 1‏
919 ‎‡a associationbetweeniqandfmr1proteinfmrpacrossthespectrumofcggrepeatexpansions‏ ‎‡A Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions‏ ‎‡9 1‏
919 ‎‡a autoimmunediseaseinmotherswiththefmr1premutationisassociatedwithseizuresintheirchildrenwithfragile10syndrome‏ ‎‡A Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome‏ ‎‡9 1‏
919 ‎‡a briefreportsensorimotorgatinginidiopathicautismandautismassociatedwithfragile10syndrome‏ ‎‡A Brief report: Sensorimotor gating in idiopathic autism and autism associated with fragile X syndrome‏ ‎‡9 1‏
919 ‎‡a womenwithfragile10associatedtremorataxiasyndrome‏ ‎‡A Women with Fragile X-associated Tremor/Ataxia Syndrome‏ ‎‡9 1‏
919 ‎‡a warburgeffectlinkedtocognitiveexecutivedeficitsinfmr1premutation‏ ‎‡A Warburg effect linked to cognitive-executive deficits in FMR1 premutation‏ ‎‡9 1‏
919 ‎‡a cognitiveneuropsychologicalphenotypeofcarriersofthefmr1premutation‏ ‎‡A The cognitive neuropsychological phenotype of carriers of the FMR1 premutation.‏ ‎‡9 1‏
919 ‎‡a rapidlyprogressingneurocognitivedisorderinamalewithfxtasandalzheimersdisease‏ ‎‡A Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease‏ ‎‡9 1‏
919 ‎‡a psychosisandcatatoniainfragile10casereportandliteraturereview‏ ‎‡A Psychosis and catatonia in fragile X: Case report and literature review‏ ‎‡9 1‏
919 ‎‡a psychiatricfeaturesinhighfunctioningadultbrotherswithfragile10spectrumdisorders‏ ‎‡A Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders.‏ ‎‡9 1‏
919 ‎‡a psychiatricdisordersamongwomenwiththefragile10premutationwithoutchildrenaffectedbyfragile10syndrome‏ ‎‡A Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome.‏ ‎‡9 1‏
919 ‎‡a prepulseinhibitioninpatientswithfragile10associatedtremorataxiasyndrome‏ ‎‡A Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome‏ ‎‡9 1‏
919 ‎‡a phenotypesofhypofrontalityinolderfemalefragile10premutationcarriers‏ ‎‡A Phenotypes of hypofrontality in older female fragile X premutation carriers‏ ‎‡9 1‏
919 ‎‡a parentdeliveredtouchscreeninterventionforchildrenwithfragile10syndrome‏ ‎‡A Parent-delivered touchscreen intervention for children with fragile X syndrome‏ ‎‡9 1‏
919 ‎‡a neuralsubstratesofexecutivedysfunctioninfragile10associatedtremorataxiasyndromefxtasabrainpotentialstudy‏ ‎‡A Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study‏ ‎‡9 1‏
919 ‎‡a methadoneuseinamalewiththefmripremutationandfxtas‏ ‎‡A Methadone use in a male with the FMRI premutation and FXTAS.‏ ‎‡9 1‏
919 ‎‡a metformintreatmentinyoungchildrenwithfragile10syndrome‏ ‎‡A Metformin treatment in young children with fragile X syndrome‏ ‎‡9 1‏
919 ‎‡a memantineforfragile10associatedtremorataxiasyndromearandomizeddoubleblindplacebocontrolledtrial‏ ‎‡A Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial.‏ ‎‡9 1‏
996 ‎‡2 BNF|11575459‏
996 ‎‡2 NII|DA0865590X‏
996 ‎‡2 DNB|121379973‏
996 ‎‡2 DNB|128400625‏
996 ‎‡2 DNB|1201215226‏
996 ‎‡2 SUDOC|265913675‏
996 ‎‡2 DNB|138627894‏
996 ‎‡2 LC|no2012131369‏
996 ‎‡2 SUDOC|063868032‏
996 ‎‡2 ISNI|0000000077132205‏
996 ‎‡2 SUDOC|234154276‏
996 ‎‡2 ISNI|0000000416962140‏
996 ‎‡2 ISNI|0000000013230922‏
996 ‎‡2 LC|n 2010049644‏
996 ‎‡2 ISNI|0000000120152093‏
996 ‎‡2 DNB|142524859‏
996 ‎‡2 DNB|120911825‏
996 ‎‡2 ISNI|0000000071827698‏
996 ‎‡2 DNB|1268947873‏
996 ‎‡2 DNB|1055442316‏
996 ‎‡2 LC|no2015036192‏
996 ‎‡2 DNB|1268940593‏
996 ‎‡2 DNB|1348916737‏
996 ‎‡2 SUDOC|266273556‏
996 ‎‡2 DNB|118045040‏
996 ‎‡2 DNB|1011536153‏
996 ‎‡2 DNB|1089254458‏
996 ‎‡2 DNB|1047977257‏
996 ‎‡2 DNB|131689401‏
996 ‎‡2 LC|no 92006191‏
996 ‎‡2 ISNI|0000000373961892‏
996 ‎‡2 DNB|1143062035‏
996 ‎‡2 DNB|137902425‏
996 ‎‡2 LC|no2020150203‏
996 ‎‡2 SZ|105822641X‏
996 ‎‡2 DNB|104283122‏
996 ‎‡2 B2Q|0000124308‏
996 ‎‡2 ISNI|0000000046685448‏
996 ‎‡2 CAOONL|ncf12030597‏
996 ‎‡2 NUKAT|n 96004784‏
996 ‎‡2 BIBSYS|97050031‏
996 ‎‡2 RERO|A026919768‏
996 ‎‡2 SUDOC|035426063‏
996 ‎‡2 DBC|87097947770238‏
996 ‎‡2 DNB|1061432653‏
996 ‎‡2 DNB|123353432‏
996 ‎‡2 ISNI|0000000392897582‏
996 ‎‡2 LC|n 93064788‏
996 ‎‡2 NUKAT|n 2004078856‏
996 ‎‡2 BNF|12270969‏
996 ‎‡2 DNB|125843259‏
996 ‎‡2 DNB|107404309X‏
996 ‎‡2 LC|no2016163642‏
996 ‎‡2 BNF|12377135‏
996 ‎‡2 LC|no2011069381‏
996 ‎‡2 DNB|1268952648‏
996 ‎‡2 RERO|A024745457‏
996 ‎‡2 DNB|132612453‏
996 ‎‡2 RERO|A005537043‏
996 ‎‡2 ISNI|0000000484560661‏
996 ‎‡2 LC|n 2022001440‏
996 ‎‡2 NII|DA10548877‏
996 ‎‡2 DNB|1057989002‏
996 ‎‡2 LC|no2003077721‏
996 ‎‡2 DNB|1037540964‏
996 ‎‡2 PLWABN|9810569704605606‏
996 ‎‡2 DNB|124962777‏
996 ‎‡2 NSK|000487459‏
996 ‎‡2 DNB|131674331‏
996 ‎‡2 ISNI|000000007190653X‏
996 ‎‡2 ISNI|0000000109686764‏
996 ‎‡2 ISNI|0000000112487416‏
996 ‎‡2 DNB|102594951X‏
996 ‎‡2 DNB|129056863‏
996 ‎‡2 DNB|135402042‏
996 ‎‡2 DNB|1062189035‏
996 ‎‡2 SUDOC|225146037‏
996 ‎‡2 NTA|070997993‏
996 ‎‡2 DNB|1268939870‏
996 ‎‡2 DNB|123509254‏
996 ‎‡2 DNB|133163180‏
996 ‎‡2 DNB|172994853‏
996 ‎‡2 NUKAT|n 2020011809‏
996 ‎‡2 DNB|131519646‏
996 ‎‡2 ISNI|0000000028358857‏
996 ‎‡2 NUKAT|n 2019207830‏
996 ‎‡2 DNB|1021934585‏
996 ‎‡2 SUDOC|254040616‏
996 ‎‡2 DNB|138361371‏
996 ‎‡2 BIBSYS|90296464‏
996 ‎‡2 CAOONL|ncf11295055‏
996 ‎‡2 NKC|pna2016936711‏
996 ‎‡2 BNE|XX5088501‏
996 ‎‡2 W2Z|1581514963494‏
996 ‎‡2 LC|n 98073636‏
996 ‎‡2 DNB|1268935794‏
996 ‎‡2 DNB|139775021‏
996 ‎‡2 PLWABN|9810543570105606‏
996 ‎‡2 DNB|1170099319‏
996 ‎‡2 DNB|1252684150‏
996 ‎‡2 ISNI|0000000057257035‏
996 ‎‡2 BNF|14474907‏
996 ‎‡2 LC|no2015022219‏
996 ‎‡2 DNB|1116555913‏
996 ‎‡2 BNF|14225222‏
996 ‎‡2 DNB|141812400‏
996 ‎‡2 NUKAT|n 2014084239‏
996 ‎‡2 DNB|1268883913‏
996 ‎‡2 SUDOC|034364358‏
996 ‎‡2 DNB|1117227723‏
996 ‎‡2 LC|no2009119128‏
996 ‎‡2 NDL|00657375‏
996 ‎‡2 DNB|13451338X‏
996 ‎‡2 BNC|981058612980506706‏
996 ‎‡2 ISNI|0000000055491100‏
996 ‎‡2 ISNI|0000000118332060‏
996 ‎‡2 DNB|125686045X‏
996 ‎‡2 RERO|A008923526‏
996 ‎‡2 ISNI|0000000012847058‏
996 ‎‡2 LC|n 88672646‏
996 ‎‡2 DNB|133859649‏
996 ‎‡2 ISNI|0000000465172508‏
996 ‎‡2 DNB|142283657‏
996 ‎‡2 DNB|128141816‏
996 ‎‡2 DNB|1049359658‏
996 ‎‡2 DNB|139810765‏
996 ‎‡2 DNB|128945443‏
996 ‎‡2 NUKAT|n 02204674‏
996 ‎‡2 DNB|1163295426‏
996 ‎‡2 DNB|1194396909‏
996 ‎‡2 DNB|1167249771‏
996 ‎‡2 LC|no 00027981‏
996 ‎‡2 ISNI|0000000019453203‏
996 ‎‡2 DNB|173546269‏
996 ‎‡2 DNB|132026511‏
996 ‎‡2 DNB|143277782‏
996 ‎‡2 BNF|13523706‏
996 ‎‡2 LC|n 2012050176‏
996 ‎‡2 JPG|500230701‏
996 ‎‡2 ISNI|0000000117667686‏
996 ‎‡2 BIBSYS|90190874‏
996 ‎‡2 DNB|141524804‏
996 ‎‡2 SUDOC|155423797‏
996 ‎‡2 LC|n 2020032570‏
996 ‎‡2 LC|n 2020032571‏
996 ‎‡2 ERRR|12185139‏
996 ‎‡2 DNB|128711531‏
996 ‎‡2 NUKAT|n 2005141021‏
996 ‎‡2 LC|nr2003024543‏
996 ‎‡2 RERO|A008689473‏
996 ‎‡2 DNB|1053491131‏
996 ‎‡2 SUDOC|070744874‏
996 ‎‡2 DNB|143509837‏
996 ‎‡2 DNB|1179465342‏
996 ‎‡2 LC|no2011193999‏
996 ‎‡2 ISNI|0000000030181659‏
996 ‎‡2 DNB|1245005448‏
996 ‎‡2 BNF|17093139‏
996 ‎‡2 J9U|987007523029105171‏
996 ‎‡2 DNB|1276367473‏
996 ‎‡2 BNF|17733605‏
996 ‎‡2 CAOONL|ncf10225558‏
996 ‎‡2 NYNYRILM|16460‏
996 ‎‡2 LC|n 88604392‏
996 ‎‡2 DNB|135520428‏
996 ‎‡2 ISNI|000000037808282X‏
996 ‎‡2 ISNI|0000000027963115‏
996 ‎‡2 NTA|073587737‏
996 ‎‡2 SUDOC|083529365‏
996 ‎‡2 BNF|13178278‏
996 ‎‡2 DNB|1268884286‏
996 ‎‡2 SUDOC|220982619‏
996 ‎‡2 DNB|1056499001‏
996 ‎‡2 DNB|118048384‏
996 ‎‡2 LC|no2020030120‏
996 ‎‡2 DNB|131478869‏
996 ‎‡2 ISNI|0000000119690775‏
996 ‎‡2 DNB|1245938991‏
996 ‎‡2 RERO|A012357770‏
996 ‎‡2 RERO|A027933608‏
996 ‎‡2 RERO|A012323067‏
996 ‎‡2 DNB|141332336‏
996 ‎‡2 DNB|122848152‏
996 ‎‡2 J9U|987007421844805171‏
996 ‎‡2 DNB|1047947714‏
996 ‎‡2 DNB|1157144039‏
996 ‎‡2 ISNI|000000043094693X‏
996 ‎‡2 DNB|1026447704‏
996 ‎‡2 ISNI|0000000008825323‏
996 ‎‡2 BIBSYS|90803597‏
996 ‎‡2 LC|no2024059447‏
996 ‎‡2 DNB|1205548912‏
996 ‎‡2 NTA|344690903‏
996 ‎‡2 LC|n 00120790‏
996 ‎‡2 NUKAT|n 2020163877‏
996 ‎‡2 NTA|255999445‏
996 ‎‡2 DNB|1048570770‏
996 ‎‡2 DNB|129004723‏
996 ‎‡2 DNB|107698441X‏
996 ‎‡2 NTA|069533555‏
996 ‎‡2 BIBSYS|99029062‏
996 ‎‡2 ISNI|0000000388186964‏
996 ‎‡2 DNB|1080486569‏
996 ‎‡2 DNB|1165679272‏
996 ‎‡2 DNB|134004000‏
996 ‎‡2 DNB|136056717‏
996 ‎‡2 ISNI|0000000079131302‏
996 ‎‡2 LC|nr 90001513‏
996 ‎‡2 DNB|1016798504‏
996 ‎‡2 LC|n 2001037487‏
996 ‎‡2 DNB|114700840X‏
996 ‎‡2 PLWABN|9810664258805606‏
996 ‎‡2 DNB|122770927‏
996 ‎‡2 DNB|1243879300‏
996 ‎‡2 SZ|1049359658‏
996 ‎‡2 DNB|126895490X‏
996 ‎‡2 LC|n 86872016‏
996 ‎‡2 NKC|ola2003188503‏
996 ‎‡2 ISNI|0000000075079818‏
996 ‎‡2 DNB|122449436‏
996 ‎‡2 ISNI|0000000055454609‏
996 ‎‡2 SUDOC|07615582X‏
996 ‎‡2 SELIBR|hx34blr2fjs006qt‏
996 ‎‡2 DNB|1019909226‏
996 ‎‡2 LC|no2015027954‏
996 ‎‡2 RERO|A027932200‏
996 ‎‡2 NUKAT|n 01720777‏
996 ‎‡2 LC|n 93105236‏
996 ‎‡2 ISNI|0000000399011537‏
996 ‎‡2 DNB|123679923‏
996 ‎‡2 BNF|12274225‏
996 ‎‡2 NUKAT|n 01196136‏
996 ‎‡2 BIBSYS|1581514963494‏
996 ‎‡2 LC|nb2009007055‏
996 ‎‡2 DNB|1153238519‏
996 ‎‡2 DNB|1137034424‏
996 ‎‡2 DE633|pe30105375‏
996 ‎‡2 BNF|14508496‏
996 ‎‡2 DNB|129955264‏
996 ‎‡2 DNB|120060108‏
996 ‎‡2 DNB|1052493696‏
996 ‎‡2 DNB|123915821‏
996 ‎‡2 BNCHL|10000000000000000169466‏
996 ‎‡2 ISNI|0000000108538444‏
996 ‎‡2 J9U|987007445165605171‏
996 ‎‡2 ISNI|0000000115879220‏
996 ‎‡2 DNB|1268880663‏
996 ‎‡2 BNF|16709771‏
996 ‎‡2 ISNI|0000000077685686‏
996 ‎‡2 BNF|13527312‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏